Insider · CIK 0001297567
CK Life Sciences Intl (Holdings) Inc
Files at DWTX (Dogwood Therapeutics, Inc.), RNAZ (Transcode Therapeutics, Inc.). First filing -, latest -.
In brief
CK Life Sciences Intl (Holdings) Inc files SEC Form 4 as director and 10% owner at DWTX (Dogwood Therapeutics, Inc.), and also at RNAZ (Transcode Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; CK Life Sciences Intl (Holdings) Inc has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Series A-1 Preferred Stockderivativeindirect: See footnote | +284 | $7.01 | $1,993 | 284 | Mar 17, 2025 |
Questions about CK Life Sciences Intl (Holdings) Inc
Answered from the filings on this page, as of the latest one.
Is CK Life Sciences Intl (Holdings) Inc buying or selling?
CK Life Sciences Intl (Holdings) Inc has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did CK Life Sciences Intl (Holdings) Inc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and CK Life Sciences Intl (Holdings) Inc has 0.
Where does CK Life Sciences Intl (Holdings) Inc file Form 4?
CK Life Sciences Intl (Holdings) Inc has filed Form 4 at DWTX (Dogwood Therapeutics, Inc.); RNAZ (Transcode Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.